EP3471730
PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.6.2017EP published:
20.10.2021EP application number:
17814169.3
EPO information:
European Patent Register
Max expiry date:
15.6.2037
Title:
PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF
Timeline
Today
16.6.2017EP application
20.10.2021EP Publication
Owner
Name:
Beta Pharma, Inc.Address:
1000 N. West Street Suite 1200, Wilmington, DE 19801, US
Inventor
Name:
GRECO, Michael, NicholasAddress:
Lansdale, PA 19446, US
Name:
COSTANZO, Michael, JohnAddress:
Warminster, PA 18974, US
Name:
GREEN, Michael, AlanAddress:
Easton, PA 18040, US
Name:
PENG, JirongAddress:
Mequon, WI 53097, US
Name:
WILDE, Victoria, LynnAddress:
Montclair, NJ 07042, US
Name:
ZHANG, DonAddress:
Princeton, NJ 08540, US
Priority
Number:
201662351749 PDate:
17.6.2016Country:
US
Classification
Categories:
A61K 31/506, C07D 403/04, C07C 55/22, A61P 35/00, C07C 309/04, C07C 309/30